-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D1n8XVa5FwvU/OS0qwt84dPHTXVgVJSDCFbg8ZbH+Qgz0aZVBDL33/iocFvVa6YH ja1D92Bfop8jc1+JwjCkBw== 0000912057-02-024380.txt : 20020614 0000912057-02-024380.hdr.sgml : 20020614 20020614172745 ACCESSION NUMBER: 0000912057-02-024380 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20020614 GROUP MEMBERS: BIOTECHNOLOGY VALUE FUND II, L.P. GROUP MEMBERS: BVF INC. GROUP MEMBERS: BVF INVESTMENTS, L.L.C. GROUP MEMBERS: BVF PARTNERS L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED MOLECULAR EVOLUTION INC CENTRAL INDEX KEY: 0001111312 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330374014 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-59733 FILM NUMBER: 02679995 BUSINESS ADDRESS: STREET 1: 3520 DUNHILL STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 5855974990 MAIL ADDRESS: STREET 1: 3520 DUNHILL STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY VALUE FUND L P CENTRAL INDEX KEY: 0000918923 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 363924731 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 227 W MONROE STREET, SUITE 4800 STREET 2: 227 W MONROE STREET, SUITE 4800 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 415-288-23 MAIL ADDRESS: STREET 1: 227 W MONROE STREET, SUITE 4800 STREET 2: 227 W MONROE STREET, SUITE 4800 CITY: CHICAGO STATE: IL ZIP: 60606 SC 13G 1 a2082466zsc13g.htm SC 13G

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(Amendment No.            )1

    BIOTECHNOLOGY VALUE FUND, L.P.    

 

 

By:

 

BVF Partners L.P., its general partner

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BIOTECHNOLOGY VALUE FUND II, L.P.

 

 

 

 

By:

 

BVF Partners L.P., its general partner

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BVF INVESTMENTS L.L.C.

 

 

 

 

By:

 

BVF Partners L.P., its manager

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BVF PARTNERS L.P.

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BVF INC.

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 


EX-1 3 a2082466zex-1.htm EXHIBIT 1
QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 1


AGREEMENT REGARDING JOINT FILING

        The undersigned, Biotechnology Value Fund, L.P., a Delaware limited partnership, Biotechnology Value Fund II, L.P., a Delaware limited partnership, BVF Investments, L.L.C., a Delaware limited liability company, BVF Partners L.P., a Delaware limited partnership, and BVF Inc., a Delaware corporation, hereby agree and acknowledge that the information required by Schedule 13G, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any amendments or supplements thereto shall also be filed on behalf of each of them.

Dated: June 14, 2002

    BIOTECHNOLOGY VALUE FUND, L.P.    

 

 

By:

 

BVF Partners L.P., its general partner

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BIOTECHNOLOGY VALUE FUND II, L.P.

 

 

 

 

By:

 

BVF Partners L.P., its general partner

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BVF INVESTMENTS L.L.C.

 

 

 

 

By:

 

BVF Partners L.P., its manager

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BVF PARTNERS L.P.

 

 

 

 

By:

 

BVF Inc., its general partner

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 

 

 

BVF INC.

 

 

 

 

By:

 

/s/  
MARK N. LAMPERT      
Mark N. Lampert
President

 

 



QuickLinks

AGREEMENT REGARDING JOINT FILING
-----END PRIVACY-ENHANCED MESSAGE-----